GBI Biomanufacturing and NanoRetinal: Pioneering Vision Restoration Therapy for Retinal Disorders A new partnership between GBI Biomanufacturing and NanoRetinal aims to develop NAR-001, a promising therapy for inherited retinal diseases. This collaboration represents significant progress in restoring vision for patients.

GBI Biomanufacturing and NanoRetinal: Pioneering Vision Restoration Therapy for Retinal Disorders #USA #Plantation #GBI_Biomanufacturing #NanoRetinal #Inherited_Retinal_Diseases